fotemustine

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

MelanomaGlioblastomaMetastatic MelanomaMetastasis

947 competitors in Melanoma

#DrugCompanyPhaseTrials

1

DTIC-Dome

Bayer

Phase 3

312

Proleukin

IIovance Biotherapeutics, Inc.

Phase 3

273

Paraplatin

AAvyxa

Phase 3

114

Spartalizumab

Novartis

Phase 3

25

KIMMTRAK

IImmunocore Ltd

Phase 3

26

Interferon-Gamma

SSPP Pharmaclon Ltd.

Phase 3

17

Adjuvant Therapy

FFudan University

Phase 3

18

fotemustine

Roche

Phase 3

29

HBI-8000

HHUYABIO International, LLC.

Phase 3

110

IBI308

Innovent Biologics (Suzhou) Co. Ltd.

Phase 3

1Show 26 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Metastatic Melanoma2 trials

Fotemustine in Treating Patients With Metastatic Melanoma

Terminated·IInstitut du Cancer de Montpellier - Val d'Aurelle·Phase 2·NCT00560118·12 enrolled

A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma

Completed·Roche·Phase 2·NCT01069627·20 enrolled

Melanoma2 trials

Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma

Completed·NNational Cancer Institute, Naples·Phase 3·NCT01359956·269 enrolled

Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

Terminated·EEuropean Organisation for Research and Treatment of Cancer - EORTC·Phase 3·NCT00110123·171 enrolled

Metastasis1 trial

A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis

Unknown status·IItalian Network for Tumor Biotherapy Foundation·Phase 3·NCT02460068·168 enrolled

Glioblastoma1 trial

A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

Completed·Roche·Phase 2·NCT01474239·91 enrolled

Details

Drug Info

Related News